enanton depot set 11.25 mg injektiokuiva-aine ja liuotin, suspensiota varten
orion corporation - leuprorelini acetas - injektiokuiva-aine ja liuotin, suspensiota varten - 11.25 mg - leuproreliini
vetox vet 10 iu/ml injektioneste, liuos
vetcare oy - oxytocin - injektioneste, liuos - 10 iu/ml - oksitosiini
equipulmin vet. 25 mikrog/ml siirappi
cp-pharma handelsgesellschaft mbh - clenbuterol hydrochloride - siirappi - 25 mikrog/ml - klenbuteroli
dilaterol vet 25 mikrog/ml siirappi
le vet. beheer b.v. - clenbuterol hydrochloride - siirappi - 25 mikrog/ml - klenbuteroli
tegsedi
akcea therapeutics ireland limited - inotersen natrium - amyloidoosi - muut hermoston huumeet - hoito vaiheen 1 tai vaiheen 2 polyneuropatia aikuisilla potilailla, joilla on perinnöllinen transthyretin amyloidoosi (hattr).
giapreza
paion deutschland gmbh - angiotensiini ii-asetaatti - hypotension; shock - reniini-angiotensiinijärjestelmään vaikuttavat aineet - giapreza on tarkoitettu hoitoon tulenkestävien hypotensio aikuisilla, joilla on septinen tai muita kaupan iskuja, jotka jäävät verenpainetta alentavaa huolimatta riittävä määrä palauttamista ja soveltamista katekoliamiinien ja muiden käytettävissä olevien vasopressorien hoitoja.
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastiset aineet - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.
nexgard combo
boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - kissat - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. eläinlääke on tarkoitettu yksinomaan, kun kaikki kolme ryhmää ovat suunnattu samaan aikaan.
celsunax
pinax pharma gmbh - joflupaani (123i) - radionuclide imaging; dementia; movement disorders - diagnostiset radiofarmaseuttiset valmisteet - tämä lääkevalmiste on tarkoitettu vain diagnostiseen käyttöön. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. aikuisilla potilailla, auttaa erottamaan todennäköinen dementia lewyn kappale-alzheimerin tauti. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
bonqat
orion corporation - pregabaliini - epilepsialääkkeet - kissat - alleviation of acute anxiety and fear associated with transportation and veterinary visits.